RE:RE:Adverse EventsI think Telesta was trying to let it be known that it won't hurt a patients chance of survival if they delay removal of bladder for MCNA treatment after BCG failure. They nailed that with Cohen's I( as I recall ) presentation. This is a major issue with the FDA and also with our Japanese friends. JMHO